The cell-specific pattern of cholecystokinin peptides in endocrine cells versus neurons is governed by the expression of prohormone convertases 1/3, 2, and 5/6.
Most peptide hormone genes are, in addition to endocrine cells, also expressed in neurons. The peptide hormone cholecystokinin (CCK) is expressed in different molecular forms in cerebral neurons and intestinal endocrine cells. To understand this difference, we examined the roles of the neuroendocrine prohormone convertases (PC) 1/3, PC2, and PC5/6 by measurement of proCCK, processing intermediates and bioactive, alpha-amidated, and O-sulfated CCK peptides in cerebral and jejunal extracts of null mice, controls, and in the PC5/6-expressing SK-N-MC cell-line. In PC1/3 null mice, the synthesis of bioactive CCK peptide in the gut was reduced to 3% of the translational product, all of which was in the form of alpha-amidated and tyrosine O-sulfated CCK-22, whereas the neuronal synthesis in the brain was largely unaffected. This is opposite to the PC2 null mice in which only the cerebral synthesis was affected. SK-N-MC cells, which express neither PC1/3 nor PC2, synthesized alone the processing intermediate, glycine-extended CCK-22. Immunocytochemistry confirmed that intestinal endocrine CCK cells in wild-type mice express PC1/3 but not PC2. In contrast, cerebral CCK neurons contain PC2 and only little, if any, PC1/3. Taken together, the data indicate that PC1/3 governs the endocrine and PC2 the neuronal processing of proCCK, whereas PC5/6 contributes only to a modest endocrine synthesis of CCK-22. The results suggest that the different peptide patterns in the brain and the gut are due to different expression of PCs.
Rehfeld
Jens F
JF
Department of Clinical Biochemistry, Rigshospitalet, Blegdamsvej 9, Copenhagen, Denmark. jens.f.rehfeld@rh.regionh.dk
Bundgaard
Jens R
JR
Hannibal
Jens
J
Zhu
Xiaorong
X
Norrbom
Christina
C
Steiner
Donald F
DF
Friis-Hansen
Lennart
L
D000818:Animals; D001921:Brain / Q000378:metabolism*; D045744:Cell Line, Tumor; D002766:Cholecystokinin / Q000096:biosynthesis*; D019858:Enteroendocrine Cells / Q000378:metabolism*; D006801:Humans; D051379:Mice; D009474:Neurons / Q000378:metabolism*; D009928:Organ Specificity; D010446:Peptide Fragments / Q000096:biosynthesis; D045664:Proprotein Convertase 1 / Q000502:physiology*; D045706:Proprotein Convertase 2 / Q000502:physiology*; D045702:Proprotein Convertase 5 / Q000502:physiology*
D010446:Peptide Fragments; D002766:Cholecystokinin; C044926:cholecystokinin 22 C-terminal fragment; D045702:Proprotein Convertase 5; D045664:Proprotein Convertase 1; D045706:Proprotein Convertase 2